IL33 and central nervous system cancer: In addition, an experiment illustrated that interleukin-33 (IL-33) positively regulated TNC expression in glioma cells, and the IL-33/ST2 axis enhanced glioma cell invasion via assembly of TNC (Zhang et al. 2019).